TPH2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, TPH2 mutation is significantly associated with the RNA expression of many other genes, with 2,646 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible TPH2-associated genes across cancer lineages are SLBP, TTC19, and PLTP. Each is linked with TPH2 in more than 4 cancer types. Because this analysis shows association rather than direction, both TPH2-to-partner and partner-to-TPH2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, SLBP grouped by TPH2-low versus TPH2-high in STAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TPH2→partner) and Y-score (partner→TPH2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
STADSLBP →+0.661+3.492<.001.00234
SKCMTTC19 →+0.586+3.195.004.00934
UCECPLTP →-0.792-2.799.007.00334
LUSCPOLE2 →+0.421+2.169.004.00334
COADMED28P4 →+0.093+2.867.007.00633
UCECZMYND19 →+0.546+3.823<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,646 associations by consensus.

SLBP by TPH2 expression — STAD

Box plot of SLBP in TPH2-low vs TPH2-high samples in STAD.

Explore this box plot interactively →

Exploration